Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the full record for a Phase II study of amivantamab in people with EGFR- or MET-amplified esophagogastric cancer, including study design, eligibility, treatment, and outcome details. It also provides study locations and information about sharing participant data.
    Difference
    44%
    Check dated 2026-11-08T12:59:56.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T13:26:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a website transition and links to updates, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:16:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error, and the displayed site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:31:48.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-11T14:11:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study page shows a 403 Forbidden error, replacing the expected content with an access-denied notice and preventing viewing the record.
    Difference
    17%
    Check dated 2026-09-20T19:47:49.000Z thumbnail image

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.